ACQUIREDStaleRelmada Therapeutics Inc · NASDAQ+120,200 sh · $504.8KFiled 11 Sept 2026·SEC Form 4·view source
ACQUIREDStaleRelmada Therapeutics Inc · NASDAQ+79,800 sh · $339.1KFiled 11 Sept 2026·SEC Form 4·view source